Overview

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
0
Participant gender:
All
Summary
This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Valsartan
Criteria
Inclusion Criteria:

- Patients with uncomplicated, essential hypertension

Exclusion Criteria:

- Severe hypertension

- History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart
rhythm

- Liver, kidney, or pancreas disease

- Insulin dependent diabetes

- Allergy to certain medications used to treat high blood pressure

Other protocol-defined exclusion criteria may apply.